Sandbox Reserved 994
From Proteopedia
(Difference between revisions)
(Added background information.) |
|||
| Line 6: | Line 6: | ||
== Background == | == Background == | ||
| - | OXA-24 is a member of the carbapenem-hydrolyzing class D β-lactamases (CHDLs), and is expressed as a resistance mechanism by the bacteria, Acinetobacter baumannii. Class D β-lactamases are clinically dangerous because they hydrolyze β-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. Class D β-lactamases are classified as OXA’s, in reference to their class designation as oxacillinases. The terminology is somewhat misleading; while they do have very strong affinity for the antibiotic oxacillin<ref name="Leonard">DOI: 10.1021/ar300327a</ref>, the OXA’s have expanded since their discovery to include penillinase, cephalosporinase, and carbapenemase activity in their spectrum. However, due to their original designation as oxacillinases, the assignment of the prefix OXA has continued to be standard designation. | + | Bacteria have cell walls which are largely made of a material called peptidoglycan, composed of two materials NAM and NAG, which the cell uses to protect against lysis from changing osmotic pressure. These two materials make alternating links of NAM and NAG which are held next to each other by NAM cross links. Without this forming, the bacterial cell wall cannot hold its structure more hypotonic solutions and the cell will lyse and die. Beta-lactams are a group of antibiotics that block the NAM cross linking in the bacterial cell wall, by “irreversibly binding to the enzymes that cross-link NAM subunits.<ref>Bauman, Robert W. "Controlling Microbial Growth in the Body: Antimicrobial Drugs." In Microbiology with Diseases by Taxonomy, 287-288. 4th ed. Glenview, IL: Pearson, 2014. </ref>” Beta-lactams are a family of antibiotics that have a four membered ring called a beta-lactam ring. To answer this bacterial cells have developed enzymes called beta-lactamases that will hydrolyze the bond between the ring’s acyl group and its nitrogen.<ref>Bauman, Robert W. "Controlling Microbial Growth in the Body: Antimicrobial Drugs." In Microbiology with Diseases by Taxonomy, 299. 4th ed. Glenview, IL: Pearson, 2014. </ref> |
| + | |||
| + | Acinetobacter baumannii is a strain of bacteria resistant to a large amount of beta-lactams producing three different types of beta-lactamases and was also involved in a nosocomial outbreak in Spain.<ref name = AB> Bou, German, Antonio Oliver, and Jesus Martinez-Beltran. "OXA-24, a Novel Class D Beta-Lactamase with Carbapenemase Activity in an Acinetobacter Baumannii Clinical Strain." Antimicrobial Agents and Chemotherapy 44, no. 6 (2000): 1556-561. Accessed February 19, 2015. http://aac.asm.org/content/44/6/1556.full</ref> It is dangerous in hospitals due to its antibacterial resistance; this will allow it to infect patients that are taking antibiotics, basically clearing the path for this bacteria to take over.<ref> Dijkshoorn, Lenie, Alexandr Nemec, and Harald Seifert. "An Increasing Threat in Hospitals: Multidrug-resistant Acinetobacter Baumannii." Nature Reviews Microbiology 5, no. 12 (2007): 939-51. Accessed February 19, 2015. http://www.nature.com/nrmicro/journal/v5/n12/full/nrmicro1789.html </ref> This strain of bacteria uses three different beta-lactamases to protect itself from antibiotics. One of which is a newly discovered enzyme called OXA-24 beta-lactamase. This enzyme is inhibited by chloride ions, tazobactam, sulbactam, and clavulanic acid, and specifically counteracts benzylpenicillin and cephaloridine.<ref name = AB /> | ||
| + | |||
| + | OXA-24 is a member of the carbapenem-hydrolyzing class D β-lactamases (CHDLs), and is expressed as a resistance mechanism by the bacteria, Acinetobacter baumannii. Class D β-lactamases are clinically dangerous because they hydrolyze β-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. Class D β-lactamases are classified as OXA’s, in reference to their class designation as oxacillinases. The terminology is somewhat misleading; while they do have very strong affinity for the antibiotic oxacillin<ref name="Leonard">DOI: 10.1021/ar300327a</ref>, the OXA’s have expanded since their discovery to include penillinase, cephalosporinase, and carbapenemase activity in their spectrum. However, due to their original designation as oxacillinases, the assignment of the prefix OXA has continued to be standard designation. | ||
== Bacterial Resistance == | == Bacterial Resistance == | ||
Revision as of 11:49, 26 February 2015
| This Sandbox is Reserved from 20/01/2015, through 30/04/2016 for use in the course "CHM 463" taught by Mary Karpen at the Grand Valley State University. This reservation includes Sandbox Reserved 987 through Sandbox Reserved 996. |
To get started:
More help: Help:Editing |
OXA-24 β-lactamase
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Bauman, Robert W. "Controlling Microbial Growth in the Body: Antimicrobial Drugs." In Microbiology with Diseases by Taxonomy, 287-288. 4th ed. Glenview, IL: Pearson, 2014.
- ↑ Bauman, Robert W. "Controlling Microbial Growth in the Body: Antimicrobial Drugs." In Microbiology with Diseases by Taxonomy, 299. 4th ed. Glenview, IL: Pearson, 2014.
- ↑ 5.0 5.1 Bou, German, Antonio Oliver, and Jesus Martinez-Beltran. "OXA-24, a Novel Class D Beta-Lactamase with Carbapenemase Activity in an Acinetobacter Baumannii Clinical Strain." Antimicrobial Agents and Chemotherapy 44, no. 6 (2000): 1556-561. Accessed February 19, 2015. http://aac.asm.org/content/44/6/1556.full
- ↑ Dijkshoorn, Lenie, Alexandr Nemec, and Harald Seifert. "An Increasing Threat in Hospitals: Multidrug-resistant Acinetobacter Baumannii." Nature Reviews Microbiology 5, no. 12 (2007): 939-51. Accessed February 19, 2015. http://www.nature.com/nrmicro/journal/v5/n12/full/nrmicro1789.html
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 Leonard DA, Bonomo RA, Powers RA. Class D beta-lactamases: a reappraisal after five decades. Acc Chem Res. 2013 Nov 19;46(11):2407-15. doi: 10.1021/ar300327a. Epub 2013 Jul, 31. PMID:23902256 doi:http://dx.doi.org/10.1021/ar300327a
- ↑ doi: https://dx.doi.org/10.3390/antibiotics3020128#sthash.iyPihLj1.dpuf
- ↑ PMCID: PMC162717
- ↑ Patrick, G. (2005). Antibacterial Agents. An Introduction to Medicinal Chemistry (3rd Ed), pages 388-414.
- ↑ Meroueh, S.O; Minasov, G; Lee, W; Shoichet, B.K; Mobashery, S. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins. J. Am. Chem Soc. (2003), 125, 9612-9618.
- ↑ Neu, Harold. "The Crisis in Antibiotic Resistance." Science (1992) 257, 5073. ProQuest Medical Library: p. 1064-1072.
- ↑ Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010 Mar;54(3):969-76. doi: 10.1128/AAC.01009-09., Epub 2009 Dec 7. PMID:19995920 doi:http://dx.doi.org/10.1128/AAC.01009-09
- ↑ 14.0 14.1 PMCID: PMC1838445
- ↑ Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother. 2000 Jun;44(6):1556-61. PMID:10817708

